Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155937 - 155937
Published: March 1, 2025
Language: Английский
Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155937 - 155937
Published: March 1, 2025
Language: Английский
Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 389 - 510
Published: Jan. 1, 2025
Language: Английский
Citations
0Vaccines, Journal Year: 2025, Volume and Issue: 13(3), P. 285 - 285
Published: March 7, 2025
Cell-derived, nanoscale extracellular vesicles (EVs) have emerged as promising tools in diagnostic, therapeutic, and vaccine applications. Their unique properties including the capability to encapsulate diverse molecular cargo well versatility surface functionalization make them ideal candidates for safe effective vehicles deliver a range of biomolecules gene editing cassettes, therapeutic proteins, glycans, glycoconjugate vaccines. In this review, we discuss recent advances development EVs derived from mammalian bacterial cells use delivery carbohydrate-based protein therapeutics We highlight key innovations EVs’ design, characterization, deployment treating diseases Alzheimer’s disease, infectious diseases, cancers. challenges their clinical translation provide perspectives future within biopharmaceutical research landscape.
Language: Английский
Citations
0Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155937 - 155937
Published: March 1, 2025
Language: Английский
Citations
0